James Whiteaker
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 4
- Endocrinology top 5%
- Microbiology top 10%
- Clinical Biochemistry top 10%
-
- Bacterial biofilms and quorum sensing 3
- Cancer therapeutics and mechanisms 2
- Biochemical and Molecular Research 2
-
- Bacterial Genetics and Biotechnology 2
-
- Antifungal resistance and susceptibility 2
- HIV/AIDS drug development and treatment 2
- Antimicrobial Resistance in Staphylococcus 2
- Co-authors
- Robert E. McLaughlinRichard A. AlmHumphrey GardnerMaxime DéraspePaul H. RoyVeronica N. KosJacques CorbeilSushmita D. Lahiri
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)SLAS DISCOVERY (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
James Whiteaker
10 papers receiving 541 citations
Peers
Comparison fields: 5 of 63
- Molecular Medicine 329
- Applied Microbiology and Biotechnology 43
- Endocrinology 79
- Microbiology 62
- Clinical Biochemistry 68
Countries citing papers authored by James Whiteaker
This map shows the geographic impact of James Whiteaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Whiteaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Whiteaker more than expected).
Fields of papers citing papers by James Whiteaker
This network shows the impact of papers produced by James Whiteaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Whiteaker. The network helps show where James Whiteaker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Whiteaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 25 | |
| 2 | 2015 | 37 | |
| 3 | 2015 | 106 | |
| 4 | 2015 | 63 | |
| 5 | 2014 | 6 | |
| 6 | 2014 | 41 | |
| 7 | 2014 | 72 | |
| 8 | 2014 | 190 | |
| 9 | 2011 | 5 | |
| 10 | 2011 | 5 |
About James Whiteaker
James Whiteaker is a scholar working on Molecular Medicine, Infectious Diseases and Microbiology, having authored 10 papers that have together received 550 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Bacterial biofilms and quorum sensing (3 papers), Cancer therapeutics and mechanisms (2 papers), Bacterial Genetics and Biotechnology (2 papers), Antifungal resistance and susceptibility (2 papers), Biochemical and Molecular Research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Molecular Medicine (329 citations), Applied Microbiology and Biotechnology (43 citations) and Endocrinology (79 citations). James Whiteaker has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Robert E. McLaughlin, Richard A. Alm, Humphrey Gardner, Maxime Déraspe, Paul H. Roy, Veronica N. Kos, Jacques Corbeil, Sushmita D. Lahiri, Jason Thresher and Stephania Livchak. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, SLAS DISCOVERY, Journal of Antimicrobial Chemotherapy, Journal of Medicinal Chemistry and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.